AMZN vs JNJ: Which Is the Better Buy?
Side-by-side comparison of Amazon.com, Inc. and Johnson & Johnson — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-05-20.
Amazon.com, Inc. · Consumer Cyclical
$259.34
+21.8% upside to fair value
Grade B
High Quality
VS
Johnson & Johnson · Healthcare
$230.69
+10.8% upside to fair value
Grade C
High Quality
QuantHub Verdict
AMZN has more upside to fair value
(+21.8%).
AMZN trades at a lower forward P/E
(26.5x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
AMZN |
JNJ |
| Current Price |
$259.34 |
$230.69 |
| Fair Value Estimate |
$316.00 |
$255.61 |
| Upside to Fair Value |
+21.8%
|
+10.8%
|
| Market Cap |
$2,789.8B |
$555.9B |
| Forward P/E |
26.5x
|
26.8x
|
| EV / EBITDA |
16.8x
|
18.5x
|
| Price / Sales |
3.9x
|
5.8x
|
| Price / FCF |
—
|
28.2x
|
| Revenue Growth YoY |
+17.0%
|
+9.9%
|
| Gross Margin |
51.8%
|
69.1%
|
| Operating Margin |
13.1%
|
26.9%
|
| Return on Equity |
21.5%
|
26.5%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
-0.81%
|
3.54%
|
| Analyst Consensus |
Strong Buy
|
Buy
|
Investment Thesis
Amazon delivered a landmark Q1 2026 with revenue of $181.5 billion up 17% year over year and diluted EPS of $2.78 versus the $1.63 consensus, driven by AWS reaccelerating to 28% growth, its fastest pace in fifteen quarters, and a record consolidated operating margin of 13.1%. AWS generated $37.6 billion in revenue at a 37.7% segment operating margin, contributing $14.2 billion in operating income…
Johnson & Johnson is a leading healthcare company focused on pharmaceuticals and medical devices following its consumer health spin-off. The business quality is high due to its durable competitive moat, diversified portfolio, and strong management with deep institutional knowledge. Despite a 52.4% decline in earnings in the most recent quarter, revenue grew 9.9% year-over-year in the same period,…
Accumulation Zones
| Metric |
AMZN |
JNJ |
| Zone Low |
$237.00 |
$191.71 |
| Zone High |
$268.60 |
$217.27 |
| In Buy Zone? |
Yes
|
No
|